|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> Lusutrombopag>> 市场分析报告 |
Lusutrombopag市场分析报告 |
|
Japan Pharma Outlook 2016: JP Giants leaning in for becoming a Speciality Global Pharma JP Giants leaning in for becoming a Speciality Global Pharma Sakigake designation – A Push from government to “Innovate”! “Essential drugs” exemption from Z2 rule- Balancing long listed pricing pressure! Authorized Generics, Biosimilars, and Patent ... Thrombopoietin Receptor Agonist Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application ... platelets; current trajectories involve lusutrombopag's five-day courses and real ... Edding Group: Edding Group's Mulpleta (lusutrombopag), a short-course oral agent ... lifts. Perioperative Innovations: Short-course lusutrombopag analogs for elective surgeries ... Japan Pharma Outlook 2015: 2015 –Year to Watch Out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives The new pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative. It pains most of the companies - whether generic or innovator. The most of the companies are revalidating their domestic (and thus overseas) strategies to ... Thrombocytopenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major thrombocytopenia markets reached a value of US$ 3.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.5% during 2024-2034. The thrombocytopenia market has been ... Global Oral Thrombopoietin Receptor Agonists Market Research Report 2025(Status and Outlook) ... Pharmaceuticals Market Segmentation (by Type) Herombopag Lusutrombopag Avatrombopag Eltrombopag Market Segmentation (by Application ... |